Drawing for CORFLUENT

USPTO serial 87822343

CORFLUENT

Reviewed by CopyMark Law Group

Reg. 5772736Status 713
Filing date
Status date
Registration date
Jun 11, 2019
Examiner
SETTLES LEWIS, SHAILA E
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CORFLUENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MERILEE J. AREVALO

MERILEE J. AREVALO GLAXOSMITHKLINEFIVE MOORE DRIVELBP, 5.5ARESEARCH TRIANGLE PARK, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesSECTION 18 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2025C18.CANCELLED SECTION 18-TOTAL—
Jul 11, 2025CANTCANCELLATION TERMINATED NO. 999999—
May 7, 2025CANGCANCELLATION GRANTED NO. 999999—
Feb 6, 2025PETCCANCELLATION INSTITUTED NO. 999999—
Nov 27, 2024BPXXEXPUNGEMENT PROCEEDING NOT INSTITUTED—
Oct 9, 2024BPXRASSIGNED TO REX/EXP PROCEEDING STAFF—
Jul 23, 2024BPETNOTICE OF SUBMISSION OF E/R PETITION TO REGISTRANT'S EMAIL—
Jul 23, 2024BPREPETITION FOR EXPUNGEMENT RECEIVED—
Jun 11, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 28, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 28, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 11, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 9, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 9, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jan 9, 2019CNSLSUSPENSION LETTER WRITTEN—
Dec 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2018ALIEASSIGNED TO LIE—
Dec 17, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 18, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Jun 18, 2018CNSLSUSPENSION LETTER WRITTEN—
Jun 18, 2018DOCKASSIGNED TO EXAMINER—
Mar 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance